Palantir (NASDAQ: PLTR) is a company with patriotism at the core of its values and vision.

Three stocks that should be on your watch list.

Just when you thought the meme stock short squeezes were over, the sector resurfaces in the mainstream headlines.

Here are the three companies I’ll be watching for this coming week.

The problem with why the company is not expanding to corporate clients is that it is facing long sales cycles.

Palantir stock fell 21% in a single day of trading after a less-than-expected earnings report. Management guidance for the future is doubtful if the company does not increase its subscriber count and earns more revenue from defense contracts.

So how bad was the miss? Honestly, there’s been much worse.

Palantir has continued its expansion into the healthcare and biotechnology sector, by joining forces with Dewpoint Therapeutics.

Let’s take a look at a couple companies that recently took another step in their growth stories.

We’ve heard the warnings for months now: a substantial bearish correction will hit the markets soon.